All In MedTech

Device Trial Radar · NCT05364502

(HALT) Embrace Hydrogel Embolic System (HES) Study of Embolization in Peripheral Arterial Bleeds

A Prospective Multicenter Single-Arm Staged Study to Evaluate the Safety and Effectiveness of Embrace™ Hydrogel Embolic For Transcatheter Embolization of Arterial Bleeding in Solid Organs and Peripheral Arteries

Last checked: Nov 20, 2026Latest source record: Nov 13, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

130

Planned (sponsor's estimate)

Start

Dec 12, 2022

Primary completion

Jan 2026

Study completion Mar 2026

Sponsor

Lead sponsor
Instylla, Inc.Not on our public-company list
Sponsor type
Industry
First posted
May 6, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the safety and effectiveness of Embrace Hydrogel Embolic System for the transcatheter embolization of peripheral arterial bleeds.

Conditions

  • Arterial Bleeding in Solid Organs and Peripheral Arteries

Interventions

  • Embrace HES including Instylla™ Delivery Kit and Instylla™ MicrocatheterDevice

    The Embrace Hydrogel Embolic System (HES) is indicated for embolization of peripheral arterial bleeds in vessels ≤6mm

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary safety endpointTime frame: Through 30 days post-index procedure
  2. Clinical SuccessTime frame: Within 30 days of the index procedure
  3. Technical SuccessTime frame: Immediately following index procedure

Locations

22 sites in 1 country. Site status is shown where the registry gives one.

  • Banner Health

    Phoenix, Arizona

  • Memorial Health Services

    Long Beach, California

  • Stanford University

    Stanford, California

19 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.